conditioned to an inferiority complex by teaching hospital consultants. What nonsense this is. GPs are specialists in minor ailments, early diagnosis, separating serious from benign conditions, distinguishing the organic from the psychogenic, which patients need a second or third opinion and from which specialist. GPs have many advantages over hospital doctors because they know the community, relatives and neighbours, as well as local beliefs and language. They have opportunities to see disease in the home, in the supermarket and in the street, hence they do not have to theorize or imagine the impact of illness they see it, in three dimensions. Moreover, with time (the fourth dimension) they can observe the evolution, progression or resolution of various conditions. However, they do have to cope with patients sent back from hospital with unhelpful letters replete with non-illuminating investigation results. Regrettably Henry Head's remark at the beginning of the century remains true 'Choose something common, you'll find nobody knows anything about it'.
We can still learn from past great figures. James Mackenzie revolutionized cardiology by direct observation, strapping a smoked drum to the back of his bicycle when he visited his Burnley patients. Pickles gathered valuable information on incubation periods and modes of transmission while a GP to five villages in Wensleydale. And Parkinson, 180 years ago, sitting in London's Hoxton Square, saw 3 of his 6 cases with 'the shaking palsy'; his description has still not been bettered. None required cooperative partners, vast series, statistics, computer or animal models, or attachment to academic departments of teaching hospitals. Disillusioned with consultant practice in London, Sir James Mackenzie returned to general practice.
Advice from Hachinski to a newly qualified doctor is invaluable: 'Distinguish information from knowledge and wisdom. Information is overwhelming but largely trivial and retrievable. Knowledge is understanding and wisdom cannot be taught, but can be acquired'4.
Dr Tilly Tansey deserves congratulations and thanks for initiating and carrying through these seminars (may we have more). We are privileged to read-no, to hear-scientists talking with contemporary colleagues about memories of discoveries, as well as groping towards understanding and misunderstandings. Doubts and contradictions, occasionally uttered, provide seeds for further progress. Above all history is shown not to be dust-dry or sterile. Few books are so intellectually stimulating or uplifting. Microalbuminuria is the most recently described of the serious diabetic microvascular complications. The concept followed the development by Professor Harry Keen in 1963 of a radioimmunoassay for the measurement of small concentrations of urinary albumin. Clinical application of this measurement was slow to be realized but in the 1 970s several researchers, notably Professor Carl Eric Mogensen, reported increased urinary albumin excretion in patients with type 1 diabetes. The early 1 980s saw the demonstration of the predictive power of microalbuminuria for the development of later full-blown diabetic nephropathy in both type 1 and type 2 diabetes. Since then there has been an explosion of interest and research into this subject with particular attention being paid to patients with type 2 diabetes in relation to cardiovascular disease. There is no doubt that the presence of microalbuminuria is an important risk-factor in any patient with diabetes and the degree of risk is proportionate to the type and duration of diabetes and the constellation of other vascular risk factors that frequently accompany this complication.
As pointed out by Professor George Alberti in the foreword to Winocour and Marshall's comprehensive and fact-filled book, the term microalbuminuria is somewhat erroneous. The urinary albumin is not small in size, rather it is present in low concentration-concentrations far below those detected with conventional dip-sticks. Danish researchers tried to change the name to 'incipient nephropathy' but not surprisingly 'microalbuminuria' stuck despite the inaccuracy and potential for mispronunciation and mis-spelling. Peter Winocour and Sally Marshall previously worked together in Professor Alberti's department in Newcastle and both made substantial research contributions. They are thus well equipped to provide a comprehensive review of microalbuminuria in relation to diabetes and general medicine.
The layout of the chapters is predictable, with the first chapter describing basic renal structure and physiology in classic textbook style. Chapter 2 covers the various methods for measuring urinary albumin in terms of both assays and types of urinary collection. Methods for screening for microalbuminuria are pertinent to all physicians caring for patients with diabetes and thus the figure depicting a scheme for screening is rather disappointing in its lack of detail, especially since specific screening guidelines exist in England and Scotland. The chapter on epidemiology I found particularly interesting as the authors review the data on urinary albumin in normal man, provide their definitions of microalbuminuria (albumin:creatinine ratio > 1.43 mg/mmol in males and > 1.80 mg/mmol in females) and highlight the association with blood pressure. The chapter that covers microalbuminuria in diabetes is admirably comprehensive especially in the collation of all the studies in type 1 and type 2 diabetes that estimate the prevalence of microalbuminuria, given that the definition of microalbuminuria is not the same in all studies. One problem when distilling so much data from studies with differing designs is knowing how to present the summary data. The tabular format selected by the authors is not entirely successful.
No self-respecting book on vascular pathophysiology can be complete without a reasonable section on nitric oxide and other endothelial dilating and contracting factors, coagulation, fibrinolysis and endothelial function, and a chapter on this theme provides a bridge into a section on microalbuminuria and cardiovascular disease. This association is particularly important since cardiovascular disease is the principal cause ofdeath in diabetes and also accounts for much morbidity. The chapter details the clustering of adverse vascular factors with microalbuminuria. A short chapter on microalbuminuria as a non-specific marker of disease precedes the final chapter, of particular interest to practising clinicians since it discusses the management of microalbuminuria. The major interventions glycaemic control, blood pressure modulation with or without ACE inhibition, and dietary protein restriction are dealt with in depth and mention is made of less well tested interventions such as aldose reductase inhibitors, heparin and lipid-lowering agents. This is a well-written and thoroughly researched book with some up-to-the-minute results on genetic factors added at the proof stage. The writing style is easy and it is clear that the authors are practising clinicians with the patient sharply in focus. The tables and figures are a little disappointing but the text makes up for this. This volume should be in all hospital libraries, and physicians with an interest in diabetes will find it an excellent resource from which to decide their own evidence-based screening and treatment protocols. Elsie Inglis' death in 1917, less than a year before the end of the Great War, was marked by an unprecedented display of national grief: Queen Mary sent condolences to the family, crowds lined Princes Street to watch the coffin pass, the body lay in state in St Giles Cathedral, and a crowded memorial service at Westminster Abbey was attended by establishment figures, envoys and dignitaries. The large congregation was there to honour, in the words of the Bishop of Oxford, a 'truly glorious woman' . . . who 'exhibited in the highest degree a combination of personal self-sacrifice and tenderest sympathy, with a rare capacity for origination and government'.
The object of his eulogy is largely forgotten today. Elsie Inglis spent most of her life working tirelessly but inconspicuously for improved medical services for women and children in Edinburgh. Hardly the stuff of which national heroines are made. In 1914, however, at the age of 50, she set up the Scottish Women's Hospitals for Foreign Service (SWH), an organization that aimed to provide medical services at the Front, run and staffed entirely by women. Under its auspices over a thousand women-doctors, nurses and support staff were sent abroad to tend the casualties in field hospitals. As Leah Leneman shows in her interesting biography, Elsie Inglis' death aroused such a public reaction entirely because of her work with the SWH, carried out during the last three years of her life. And indeed her achievements in that short time were remarkable. Inglis qualified in medicine in Scotland in 1892. A spell in London at Elizabeth Garrett Anderson's New Hospital for Women opened her eyes to the lot of the working class women and awakened an interest in the Suffrage movement. She became an active member of an Edinburgh group on her return to Scotland, and opened a small hospital for women in 1899. The refusal by the War Office and RAMC to take up offers of help from women doctors at the outbreak of World War I goaded Inglis into action; in September 1914 the formation of the SWH was announced, and fund-raising began. Despite opposition from the War Office, enough money was raised for the first two units to cross the Channel at the end of the year. Inglis left headquarters for good early in 1915 to work in the field, and went out with a unit to work in Serbia. She rapidly developed a deep affection for the Serbs which was to keep her in the country, working in conditions which were to worsen progressively as time passed. Typhus, dysentery and the weather were the women's greatest enemies: disease could be tackled by cleanliness and isolation, but the only defence against the Serbian winter was to wear
